209 related articles for article (PubMed ID: 6578086)
1. Purified human basophils and mast cells: current concepts of mediator release.
Schulman ES; MacGlashan DW; Schleimer RP; Peters SP; Kagey-Sobotka A; Newball HH; Lichtenstein LM
Eur J Respir Dis Suppl; 1983; 128 (Pt 1)():53-61. PubMed ID: 6578086
[TBL] [Abstract][Full Text] [Related]
2. Anaphylactic- and calcium-dependent generation of prostaglandin D2 (PGD2), thromboxane B2, and other cyclooxygenase products of arachidonic acid by dispersed human lung cells and relationship to histamine release.
Holgate ST; Burns GB; Robinson C; Church MK
J Immunol; 1984 Oct; 133(4):2138-44. PubMed ID: 6206153
[TBL] [Abstract][Full Text] [Related]
3. Nimesulide, a sulfonanilide nonsteroidal anti-inflammatory drug, inhibits mediator release from human basophils and mast cells.
Casolaro V; Meliota S; Marino O; Patella V; de Paulis A; Guidi G; Marone G
J Pharmacol Exp Ther; 1993 Dec; 267(3):1375-85. PubMed ID: 7505332
[TBL] [Abstract][Full Text] [Related]
4. Comparative studies of mediator release from guinea pig lung mast cells and basophils.
Undem BJ; Brendel JB; Hirth T; Buckner CK; Graziano FM
Am Rev Respir Dis; 1986 May; 133(5):763-8. PubMed ID: 2422992
[TBL] [Abstract][Full Text] [Related]
5. Human heart mast cells. Isolation, purification, ultrastructure, and immunologic characterization.
Patella V; Marinò I; Lampärter B; Arbustini E; Adt M; Marone G
J Immunol; 1995 Mar; 154(6):2855-65. PubMed ID: 7533185
[TBL] [Abstract][Full Text] [Related]
6. Human uterine mast cells. Isolation, purification, characterization, ultrastructure, and pharmacology.
Massey WA; Guo CB; Dvorak AM; Hubbard WC; Bhagavan BS; Cohan VL; Warner JA; Kagey-Sobotka A; Lichtenstein LM
J Immunol; 1991 Sep; 147(5):1621-7. PubMed ID: 1715365
[TBL] [Abstract][Full Text] [Related]
7. Comparative studies of human basophils and mast cells.
MacGlashan DW; Schleimer RP; Peters SP; Schulman ES; Adams GK; Sobotka AK; Newball HH; Lichtenstein LM
Fed Proc; 1983 May; 42(8):2504-9. PubMed ID: 6301890
[TBL] [Abstract][Full Text] [Related]
8. Studies with purified human basophils and mast cells.
Lichtenstein LM; Schleimer RP; Peters SP; Kagey-Sobotka A; Adkinson NF; Adams GK; Schulman ES; MacGlashan DW
Monogr Allergy; 1983; 18():259-64. PubMed ID: 6196631
[No Abstract] [Full Text] [Related]
9. The role of basophils in allergic disease.
Knol EF; Mul FP; Lie WJ; Verhoeven AJ; Roos D
Eur Respir J Suppl; 1996 Aug; 22():126s-131s. PubMed ID: 8871057
[TBL] [Abstract][Full Text] [Related]
10. Purification and characterization of human skin mast cells. Evidence for human mast cell heterogeneity.
Lawrence ID; Warner JA; Cohan VL; Hubbard WC; Kagey-Sobotka A; Lichtenstein LM
J Immunol; 1987 Nov; 139(9):3062-9. PubMed ID: 2444649
[TBL] [Abstract][Full Text] [Related]
11. The ascomycin macrolactam pimecrolimus (Elidel, SDZ ASM 981) is a potent inhibitor of mediator release from human dermal mast cells and peripheral blood basophils.
Zuberbier T; Chong SU; Grunow K; Guhl S; Welker P; Grassberger M; Henz BM
J Allergy Clin Immunol; 2001 Aug; 108(2):275-80. PubMed ID: 11496246
[TBL] [Abstract][Full Text] [Related]
12. Heterogeneity of human mast cells.
Schulman ES; Kagey-Sobotka A; MacGlashan DW; Adkinson NF; Peters SP; Schleimer RP; Lichtenstein LM
J Immunol; 1983 Oct; 131(4):1936-41. PubMed ID: 6194221
[TBL] [Abstract][Full Text] [Related]
13. Basic characteristics of human lung mast cell desensitization.
MacGlashan D; Lichtenstein LM
J Immunol; 1987 Jul; 139(2):501-5. PubMed ID: 2439588
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandin D2 generation after activation of rat and human mast cells with anti-IgE.
Lewis RA; Soter NA; Diamond PT; Austen KF; Oates JA; Roberts LJ
J Immunol; 1982 Oct; 129(4):1627-31. PubMed ID: 6809826
[TBL] [Abstract][Full Text] [Related]
15. Effect of prostaglandin D2 in modulating histamine release from human basophils.
Peters SP; Kagey-Sobotka A; MacGlashan DW; Lichtenstein LM
J Pharmacol Exp Ther; 1984 Feb; 228(2):400-6. PubMed ID: 6198512
[TBL] [Abstract][Full Text] [Related]
16. The pharmacologic control of mediator release from human basophils and mast cells.
Peters SP; Naclerio RM; Schleimer RP; MacGlashan DW; Pipkorn U; Lichtenstein LM
Respiration; 1986; 50 Suppl 2():116-22. PubMed ID: 3494282
[TBL] [Abstract][Full Text] [Related]
17. Characterization of inflammatory mediator release from purified human lung mast cells.
Schleimer RP; MacGlashan DW; Peters SP; Pinckard RN; Adkinson NF; Lichtenstein LM
Am Rev Respir Dis; 1986 Apr; 133(4):614-7. PubMed ID: 3485946
[TBL] [Abstract][Full Text] [Related]
18. Human IgE+ and IgE- are not equivalent to mouse highly cytokinergic IgE.
Xie L; Schroeder JT; Langdon JM; Sora-Scott RS; Kawakami T; MacDonald SM
J Allergy Clin Immunol; 2008 Apr; 121(4):1027-33. PubMed ID: 18234322
[TBL] [Abstract][Full Text] [Related]
19. Effects of dexamethasone on mediator release from human lung fragments and purified human lung mast cells.
Schleimer RP; Schulman ES; MacGlashan DW; Peters SP; Hayes EC; Adams GK; Lichtenstein LM; Adkinson NF
J Clin Invest; 1983 Jun; 71(6):1830-5. PubMed ID: 6134755
[TBL] [Abstract][Full Text] [Related]
20. Disassociation of the release of histamine and arachidonic acid metabolites from osmotically activated basophils and human lung mast cells.
Eggleston PA; Kagey-Sobotka A; Proud D; Adkinson NF; Lichtenstein LM
Am Rev Respir Dis; 1990 Apr; 141(4 Pt 1):960-4. PubMed ID: 1691604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
